T. ANDO, M. MINAMI, K. ISHIGURO, O. MAEDA, O. WATANABE, T. MIZUNO, T. FUJITA, H. TAKAHASHI, M. NOSHIRO, H. GOTO
{"title":"Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication","authors":"T. ANDO, M. MINAMI, K. ISHIGURO, O. MAEDA, O. WATANABE, T. MIZUNO, T. FUJITA, H. TAKAHASHI, M. NOSHIRO, H. GOTO","doi":"10.1111/j.1746-6342.2006.00026.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Summary</h3>\n </section>\n \n <section>\n \n <h3> Background</h3>\n \n <p>Recent evidence suggests that <i>Helicobacter pylori</i> infection is involved in the pathogenesis of extra-gastrointestinal diseases such as coronary heart disease.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>To determine the association of <i>H. pylori</i> infection with biochemical parameters of atherosclerosis in the serum.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>One hundred and fifty-nine patients with <i>H. pylori</i>-positive peptic ulcer (duodenal ulcer, n=89; gastric ulcer, n=70) receiving triple therapy were studied prospectively for up to 3 years for clinical parameters associated with inflammation and cardiovascular events. Blood was tested at the time of annual check-up.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Eradication was successful in 137 patients (86%), and body weight, body mass index (BMI) and TG levels increased gradually each year. No significant hanges were seen in plasma levels of total cholesterol, interleukin-6 or interleukin-8, whereas those of HDL-C increased significantly, and those of C-reactive protein, fibrinogen and LDL-C decreased.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>There is evidence for the possible implication of <i>H. pylori</i> infection in the etiology of cardiovascular events via its exacerbation of or influence on risk factors of atherogenesis.</p>\n </section>\n </div>","PeriodicalId":50822,"journal":{"name":"Alimentary Pharmacology & Therapeutics Symposium Series","volume":"2 1","pages":"58-64"},"PeriodicalIF":0.0000,"publicationDate":"2006-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1746-6342.2006.00026.x","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics Symposium Series","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1746-6342.2006.00026.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Summary
Background
Recent evidence suggests that Helicobacter pylori infection is involved in the pathogenesis of extra-gastrointestinal diseases such as coronary heart disease.
Aim
To determine the association of H. pylori infection with biochemical parameters of atherosclerosis in the serum.
Methods
One hundred and fifty-nine patients with H. pylori-positive peptic ulcer (duodenal ulcer, n=89; gastric ulcer, n=70) receiving triple therapy were studied prospectively for up to 3 years for clinical parameters associated with inflammation and cardiovascular events. Blood was tested at the time of annual check-up.
Results
Eradication was successful in 137 patients (86%), and body weight, body mass index (BMI) and TG levels increased gradually each year. No significant hanges were seen in plasma levels of total cholesterol, interleukin-6 or interleukin-8, whereas those of HDL-C increased significantly, and those of C-reactive protein, fibrinogen and LDL-C decreased.
Conclusion
There is evidence for the possible implication of H. pylori infection in the etiology of cardiovascular events via its exacerbation of or influence on risk factors of atherogenesis.